Friday, November 27, 2020 12:47:09 PM
Yes the FCEl/EV market has been on fire got a large portfolio now but keep a few smaller plays for the "Zip code changer".
Learned a few lessons here and there but still follow the boards of losers for the reminder..
I am amazed that Revive hasn't been picked up by larger investors yet and still cant work out why it took so long to get the phase 3 trials up and running but now we are well into them I would hope for som equick news.
people more knowledgeable in the matter than me seem confident the similarity with NAC should give great results. was worth moving some from Bloom Calls to here for any news over the weekend.
Learned a few lessons here and there but still follow the boards of losers for the reminder..
I am amazed that Revive hasn't been picked up by larger investors yet and still cant work out why it took so long to get the phase 3 trials up and running but now we are well into them I would hope for som equick news.
people more knowledgeable in the matter than me seem confident the similarity with NAC should give great results. was worth moving some from Bloom Calls to here for any news over the weekend.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
